Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CordSTEM-ST in premature ovarian insufficiency
NCT06578039Phase 1Completed
- Sponsor
- CHA Biotech
- Start
- Aug 2024
- Primary completion
- Apr 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of CordSTEM-ST in premature ovarian insufficiency (POI) (2 arms), sponsored by CHA Biotech. Primary endpoints: Adverse Events at 6 months, Laboratory Test Abnormalities at 6 months and 2 more. Started Aug 2024; status: completed.
02
Drugs
CordSTEM-ST
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT06578039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06578039.